Irafasha C. Casmil
BC V6T1Z3, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Formulation and administration timing of lipid derivatized JAK-inhibitor and corticosteroid modulate saRNA-LNP inflammation and expression.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 02, 2025
Divergent Delivery and Expression Kinetics of Lipid and Polymeric Nanoparticles across mRNA Modalities.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 16, 2025
Laminar fluid ejection device enables high yield and preservation of mRNA and SaRNA LNP formulations.
Journal: Scientific reports
Published: April 08, 2025
Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteers.
Journal: Nature communications
Published: November 05, 2024
The advent of clinical self-amplifying RNA vaccines.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: October 31, 2024
Alphaviral backbone of self-amplifying RNA enhances protein expression and immunogenicity against SARS-CoV-2 antigen.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: October 28, 2024
Can self-amplifying RNA vaccines and viruses exchange genetic material?
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 29, 2024
Delivery vehicle and route of administration influences self-amplifying RNA biodistribution, expression kinetics, and reactogenicity.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: March 31, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026